ursodeoxycholic acid has been researched along with Graft vs Host Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Björklund, A; El-Serafi, I; Mattsson, J; Remberger, M; Ringdèn, O; Sundin, M; Törlén, J; Winiarski, J | 1 |
| Alsubait, S; Nassereddine, S; Tabbara, I | 1 |
| Abdel-Rahman, F; Adil, SN; Ahmed, P; Alabdulaaly, A; Alimoghaddam, K; Aljurf, M; Alseraihy, A; Bazarbachi, A; Bekadja, MA; Ben Othman, T; Benchekroun, S; Dennison, D; Elhaddad, A; Ghavamzadeh, A; Hamidieh, A; Hamladji, R; Hussain, F; Ibrahim, A; Jarrar, M; Mohamed, SY; Ramzi, M; Rasheed, W | 1 |
| Hägglund, H; Juvonen, E; Mattsson, J; Nihtinen, A; Remberger, M; Remes, K; Ringdén, O; Ruutu, T; Volin, L | 1 |
| Eriksson, B; Hägglund, H; Juvonen, E; Parkkali, T; Remberger, M; Remes, K; Ringdén, O; Ruutu, T; Volin, L | 1 |
| Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O | 1 |
| Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M | 1 |
| Akan, H; Arat, M; Erden, E; Idilman, R; Karayalçin, S; Soydan, EA; Soykan, I | 1 |
| Luketic, VA; Sanyal, AJ | 1 |
| Parés, A; Rodés, J | 1 |
| Shiraki, K; Tameda, Y | 1 |
| Benkerrou, M; de Graeff-Meeder, BR; Fischer, A; Haddad, E; Patey, N; Spliet, WG; Wulffraat, NM | 1 |
| Saksena, S; Tandon, RK | 1 |
| Allerton, JP; Callander, N; Essell, JH; Halvorson, R; Harman, GS; Lew, V; Lewis, SK; Schroeder, MT; Snyder, M; Thompson, JM | 1 |
| Kowdley, KV | 1 |
| Erlinger, S | 1 |
| Fisher, LD; Fried, RH; McDonald, GB; Murakami, CS; Sullivan, KM; Willson, RA | 1 |
6 review(s) available for ursodeoxycholic acid and Graft vs Host Disease
| Article | Year |
|---|---|
Sinusoidal Obstruction Syndrome (Veno-occlusive Disease) Following Hematopoietic Stem Cell Transplant: Insights and Therapeutic Advances.
Topics: Anticoagulants; Biomarkers; Conservative Treatment; Cytokines; Endothelial Cells; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heparin; Hepatic Veno-Occlusive Disease; Humans; Polydeoxyribonucleotides; Risk Factors; Ursodeoxycholic Acid | 2018 |
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid | 1994 |
[Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
Topics: Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Female; Graft vs Host Disease; Hepatitis; Hepatitis, Alcoholic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid | 1996 |
[Chronic non-suppurative destructive cholangitis (CNSDC)].
Topics: Autoimmune Diseases; Graft vs Host Disease; Hepatitis C; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid in the treatment of liver diseases.
Topics: Biliary Tract Diseases; Cholagogues and Choleretics; Chronic Disease; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Diseases; Liver Transplantation; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid | 1997 |
Ursodeoxycholic acid therapy in hepatobiliary disease.
Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid | 2000 |
4 trial(s) available for ursodeoxycholic acid and Graft vs Host Disease
| Article | Year |
|---|---|
Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study.
Topics: Adult; Bilirubin; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Myeloablative Agonists; Prospective Studies; Recurrence; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Alanine Transaminase; Bilirubin; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Infant; Liver Diseases; Male; Middle Aged; Prospective Studies; Survival Analysis; Transplantation, Homologous; Ursodeoxycholic Acid | 2002 |
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cholagogues and Choleretics; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Placebos; Survival Rate; Transplantation, Homologous; Ursodeoxycholic Acid | 1998 |
Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver.
Topics: Bilirubin; Cholestasis; Chronic Disease; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |
7 other study(ies) available for ursodeoxycholic acid and Graft vs Host Disease
| Article | Year |
|---|---|
Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Acetylcysteine; Adolescent; Adult; Busulfan; Capillaries; Child; Child, Preschool; Cholagogues and Choleretics; Cyclophosphamide; Drug Monitoring; Female; Free Radical Scavengers; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Liver; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Risk Assessment; Transplantation Conditioning; Ursodeoxycholic Acid; Young Adult | 2020 |
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Topics: Academies and Institutes; Anti-Infective Agents; Cyclosporine; Data Collection; Graft vs Host Disease; Growth Hormone; Hematopoietic Stem Cell Transplantation; Humans; Mediterranean Region; Methotrexate; Pulmonary Veno-Occlusive Disease; Transplantation, Autologous; Transplantation, Homologous; Ursodeoxycholic Acid | 2013 |
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Hepatitis; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hypercholesterolemia; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Middle Aged; Prednisolone; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Ursodeoxycholic Acid | 2004 |
Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Liver Diseases; Male; Middle Aged; Prospective Studies; Transplantation Conditioning; Ursodeoxycholic Acid | 2005 |
Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: the effect of ursodeoxycholic acid.
Topics: Adrenal Cortex Hormones; Bile Duct Diseases; Bilirubin; Bone Marrow Transplantation; Cholagogues and Choleretics; Cyclosporine; Fibrosis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Liver Diseases; Male; Severe Combined Immunodeficiency; Skin Diseases; Ursodeoxycholic Acid | 1997 |
Chronic graft-vs.-host disease of the liver: another indication of ursodeoxycholic acid?
Topics: Bone Marrow Transplantation; Graft vs Host Disease; Humans; Liver Diseases; Ursodeoxycholic Acid | 1992 |